Leila Godfrey
Oxford, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Safety and immunogenicity of the invasive non-typhoidal Salmonella (iNTS)-GMMA vaccine: a first-in-human, randomised, dose escalation trial.
Journal: EBioMedicine
Published: March 25, 2025
Proficiency tests to evaluate the impact on assay outcomes of harmonized influenza-specific Intracellular Cytokine Staining (ICS) and IFN-ɣ Enzyme-Linked ImmunoSpot (ELISpot) protocols.
Journal: Journal of immunological methods
Published: April 16, 2023
CD56bright natural killer cells preferentially kill proliferating CD4+ T cells.
Journal: Discovery immunology
Published: March 29, 2023
ChAdOx1 nCoV-19 vaccination generates spike-specific CD8+ T cells in aged mice.
Journal: Immunology and cell biology
Published: February 20, 2023
Evaluation of T cell responses to naturally processed variant SARS-CoV-2 spike antigens in individuals following infection or vaccination.
Journal: Cell reports
Published: January 19, 2023
Persistence of the immune response after two doses of ChAdOx1 nCov-19 (AZD1222): 1 year of follow-up of two randomized controlled trials.
Journal: Clinical and experimental immunology
Published: November 01, 2022
Tfh cells and the germinal center are required for memory B cell formation & humoral immunity after ChAdOx1 nCoV-19 vaccination.
Journal: Cell reports. Medicine
Published: July 04, 2022
Booster Vaccination Against SARS-CoV-2 Induces Potent Immune Responses in People With Human Immunodeficiency Virus.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: May 18, 2022
Durability of ChAdOx1 nCoV-19 vaccination in people living with HIV.
Journal: JCI insight
Published: December 08, 2021
Last Updated: 09/26/2026